Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary Hypertension

Summary

This study aims to investigate therapies for exercise induced pulmonary hypertension (EiPH). This is a condition that effects the blood vessels in the lungs and causes shortness of breath with activity. Currently, there are very limited treatment options for this condition. Inhaled treprostinil, also known as Tyvaso, is a medication used to treat other forms of lung disease and is safe and well tolerated. This study will measure the ability of Tyvaso to improve symptoms related to EiPH and improve performance on exercise testing.

Timeline

Start

2025-10-01

Primary completion

2027-07-01

Completion

2027-07-01

Drugs

Indications